BUZZ-Australia's CSL up as Morgan Stanley remains positive on plasma division

Reuters

Nov 04

BUZZ-Australia's CSL up as <a href="https://laohu8.com/S/MTK">Morgan Stanley</a> remains positive on plasma division

** Shares of CSL CSL.AX rise as much as 1.8% to A$178.47, set to snap two straight sessions of losses

** Morgan Stanley sees a favourable medium- to long-term outlook in demand for immunoglobulin (Ig), a component found in blood plasma

** Notes distributed volume of Ig in the U.S. has increased strongly over time, with high single-digit annual growth recorded over the past 3, 10 and 15 years

** Brokerage sees headroom for growth in the U.S. across various therapies, including cell therapy; also sees scope for increased in ex-U.S. markets

** MS sees potential for Ig outlook alongside yield initiatives to support a gross margin recovery for CSL Behring, co's plasma segment

** Brokerage retains "overweight" tag, price target A$248

** Stock down 37.3% YTD, including the day's moves

(Reporting by Nikita Maria Jino in Bengaluru)

((Nikita.Jino@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2580790342"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2580790342\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2580790342?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-04 10:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2580790342","market":"us","top_or_hot":-1,"title":"BUZZ-Australia's CSL up as Morgan Stanley remains positive on plasma division","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's CSL up as <a href=\"https://laohu8.com/S/MTK\">Morgan Stanley</a> remains positive on plasma division</title></head><body><p>   ** Shares of CSL <span>CSL.AX</span> rise as much as 1.8% to A$178.47, set to snap two straight sessions of losses</p><p>** <a href=\"https://laohu8.com/S/MSPQL\">Morgan Stanley</a> sees a favourable medium- to long-term outlook in demand for immunoglobulin (Ig), a component found in blood plasma</p><p>** Notes distributed volume of Ig in the U.S. has increased strongly over time, with high single-digit annual growth recorded over the past 3, 10 and 15 years</p><p>** Brokerage sees headroom for growth in the U.S. across various therapies, including cell therapy; also sees scope for increased in ex-U.S. markets</p><p>** MS sees potential for Ig outlook alongside yield initiatives to support a gross margin recovery for CSL Behring, co's plasma segment</p><p>** Brokerage retains \"overweight\" tag, price target A$248</p><p>** Stock down 37.3% YTD, including the day's moves</p><p>(Reporting by Nikita Maria Jino in Bengaluru)</p><p>((Nikita.Jino@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Australia's CSL up as Morgan Stanley remains positive on plasma division</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Australia's CSL up as Morgan Stanley remains positive on plasma division\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-04 10:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's CSL up as <a href=\"https://laohu8.com/S/MTK\">Morgan Stanley</a> remains positive on plasma division</title></head><body><p>   ** Shares of CSL <span>CSL.AX</span> rise as much as 1.8% to A$178.47, set to snap two straight sessions of losses</p><p>** <a href=\"https://laohu8.com/S/MSPQL\">Morgan Stanley</a> sees a favourable medium- to long-term outlook in demand for immunoglobulin (Ig), a component found in blood plasma</p><p>** Notes distributed volume of Ig in the U.S. has increased strongly over time, with high single-digit annual growth recorded over the past 3, 10 and 15 years</p><p>** Brokerage sees headroom for growth in the U.S. across various therapies, including cell therapy; also sees scope for increased in ex-U.S. markets</p><p>** MS sees potential for Ig outlook alongside yield initiatives to support a gross margin recovery for CSL Behring, co's plasma segment</p><p>** Brokerage retains \"overweight\" tag, price target A$248</p><p>** Stock down 37.3% YTD, including the day's moves</p><p>(Reporting by Nikita Maria Jino in Bengaluru)</p><p>((Nikita.Jino@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7511","symbol_name":"ESG概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nL6N3WG05E:1","article_id":"2580790342","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2580790342","pubTimestamp":1762223244,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Australia's CSL up as Morgan Stanley remains positive on plasma division   ** Shares of CSL CSL.AX rise as much as 1.8% to A$178.47, set to snap two straight sessions of losses** Morgan Stanley sees a favourable medium- to long-term outlook in demand for immunoglobulin , a component found in blood plasma** Notes distributed volume of Ig in the U.S. has increased strongly over time, with high single-digit annual growth recorded over the past 3, 10 and 15 years** Brokerage sees headroom for growth in the U.S. across various therapies, including cell therapy; also sees scope for increased in ex-U.S. markets** MS sees potential for Ig outlook alongside yield initiatives to support a gross margin recovery for CSL Behring, co's plasma segment** Brokerage retains \"overweight\" tag, price target A$248** Stock down 37.3% YTD, including the day's moves","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7511":"ESG概念","BK7067":"生物科技","BK7508":"医药生物股","BK7501":"新冠治疗股","CSL.AU":"CSL LIMITED"},"translate_title":"摩根士丹利对血浆部门保持乐观态度，澳大利亚CSL上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CSL.AU":0.9},"content_text":"BUZZ-Australia's CSL up as Morgan Stanley remains positive on plasma division   ** Shares of CSL CSL.AX rise as much as 1.8% to A$178.47, set to snap two straight sessions of losses** Morgan Stanley sees a favourable medium- to long-term outlook in demand for immunoglobulin (Ig), a component found in blood plasma** Notes distributed volume of Ig in the U.S. has increased strongly over time, with high single-digit annual growth recorded over the past 3, 10 and 15 years** Brokerage sees headroom for growth in the U.S. across various therapies, including cell therapy; also sees scope for increased in ex-U.S. markets** MS sees potential for Ig outlook alongside yield initiatives to support a gross margin recovery for CSL Behring, co's plasma segment** Brokerage retains \"overweight\" tag, price target A$248** Stock down 37.3% YTD, including the day's moves(Reporting by Nikita Maria Jino in Bengaluru)((Nikita.Jino@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}